Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection

Journal of Endourology

Volumn 19, Issue 7, 2005, Pages 880-882

  Smith, Christopher P ^a   Chancellor, Michael B ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BOTULINUM TOXIN A;

ARTICLE; CLINICAL ARTICLE; CYSTOSCOPE; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESPONSE; GENERAL CONDITION IMPROVEMENT; HUMAN; IDIOPATHIC DISEASE; INJECTION SITE; NEEDLE; OUTCOMES RESEARCH; OVERACTIVE BLADDER; PRIORITY JOURNAL; RELIABILITY; RESIDUAL URINE; SUBMUCOSAL DRUG ADMINISTRATION; URINE RETENTION;

BOTULINUM TOXIN TYPE A; CYSTOSCOPES; HUMANS; INJECTIONS; MUCOUS MEMBRANE; NEUROMUSCULAR AGENTS; URINARY INCONTINENCE;

EID: 26444571818     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2005.19.880     Document Type: Article

References (13)

1. Ermengem E van. Über einen neuen anaeroben Bacillus and seine Beziehungen zum Botulisms. Zeitsch Hyg Infekt 1897;26:1.
2. Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB. Botulinum A toxin as a treatment of detrusor-sphincter dyssynergia: A prospective study in 24 spinal cord injury patients. J Urol 1996; 155:1023.
3. Petit H, Wiart E, Gaujard E, LeBreton F, Ferriere JM, Lagueny A, Joseph PA, Barat M. Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 1998; 36:91-94.
4. Dykstra DD, Sidi A. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: A double blind study. Arch Phys Med Rehabil 1990;71:24.
5. Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 1988;139;919.
6. Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results. J Urol 2000;164:692.
7. Radziszewski P, Dobronski P, Borkowski A. Treatment of the non-neurogenic storage and voiding disorders with the chemical denervation caused by botulinum toxin type A: A pilot study. Neurourol Urodynam 2001;20:410.
8. Zermann DH, Ishigooka M, Schubert J, Schmidt RA. Trigonum and bladder base injection of botulinum toxin A (BTX) in patients with severe urgency-frequency-syndrome refractory to conservative medical treatment and electrical stimulation. Neurourol Urodynam 2001;20:412.
9. Loch A, Loch T, Osterhage J, Alloussi S, Stockle M. Botulinum-A toxin detrusor injections in the treatment of non-neurologic and neurologic cases of urge incontinence. J Urol 2003;169:124.
10. Chancellor MB, O'Leary M, Erickson J, Cannon TW, Chermansky C, Leng W, Smith CP. Successful use of bladder botulinum toxin injection to treat refractory overactive bladder. J Urol 2003; 169:351.
11. Smith CP, Chancellor MB. Emerging role of botulinum toxin in the treatment of voiding dysfunction. J Urol 2004;171:2128.
12. Stohrer M, Schurch B, Kramer G, Schmid D, Gaul G, Hauri D. Botulinum A-toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: A new alternative to medical and surgical procedures? Neurourol Urodynam 1999;18:401.
13. Kim HS, Hwang JH, Jeong ST, Lee YT, Lee PK, Suh YL et al. Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis. Dev Med Child Neurol 2003;45:200.